Can side effects of steroid treatments be minimized by the temporal aspects of delivery method?

Bibliography

• van Staa TP, Leufkens HG, Abenhaim L, et al. Use of oral corticosteroids in the United Kingdom. QJM 2000;93(2):105-11
   PubMed Web of Science ®Google Scholar
• Overman RA, Yeh JY, Deal CL. Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care Res (Hoboken) 2013;65(2):294-8
   PubMed Web of Science ®Google Scholar
• Busse WW, Lenfant C, Lemanske RF Jr. Asthma guidelines: a changing paradigm to improve asthma care. J Allergy Clin Immunol 2002;110(5):703-5
   PubMed Web of Science ®Google Scholar
• Scadding GK. Corticosteroids in the treatment of pediatric allergic rhinitis. J Allergy Clin Immunol 2001;108(1 Suppl):S59-64
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johansson H, Oden A, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004;19(6):893-9
   PubMed Web of Science ®Google Scholar
• Curtis JR, Westfall AO, Allison J, et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum 2006;55(3):420-6
   PubMed Web of Science ®Google Scholar
• Kenna HA, Poon AW, de los Angeles CP, Koran LM. Psychiatric complications of treatment with corticosteroids: review with case report. Psychiatry Clin Neurosci 2011;65(6):549-60
   PubMed Web of Science ®Google Scholar
• Pereira RM, Carvalho JF, Canalis E. Glucocorticoid-induced osteoporosis in rheumatic diseases. Clinics 2010;65(11):1197-205
   PubMed Web of Science ®Google Scholar
• McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol 2008;20(2):131-7
   PubMed Web of Science ®Google Scholar
• Leung DY, Bloom JW. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2003;111(1):3-22; quiz 23
   PubMed Web of Science ®Google Scholar
• Crown A, Lightman S. Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol (Oxf) 2005;63(5):483-92
   PubMed Web of Science ®Google Scholar
• Lovas K, Husebye ES. Replacement therapy in Addison’s disease. Expert Opin Pharmacother 2003;4(12):2145-9
   PubMed Web of Science ®Google Scholar
• Ross RJ, Rostami-Hodjegan A. Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasia. Horm Res 2005;64(Suppl 2):67-70
   PubMedGoogle Scholar
• Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G. Premature mortality in patients with Addison’s disease: a population-based study. J Clin Endocrinol Metab 2006;91(12):4849-53
   PubMed Web of Science ®Google Scholar
• Sherlock M, Ayuk J, Tomlinson JW, et al. Mortality in patients with pituitary disease. Endocr Rev 2010;31(3):301-42
   PubMed Web of Science ®Google Scholar
• Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336(8710):285-8
   PubMed Web of Science ®Google Scholar
• Frisch H, Waldhauser F, Lebl J, et al. Congenital adrenal hyperplasia: lessons from a multinational study. Horm Res 2002;57(Suppl 2):95-101
   PubMedGoogle Scholar
• Nermoen I, Husebye ES, Svartberg J, Lovas K. Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur J Endocrinol 2010;163(3):453-9
   PubMed Web of Science ®Google Scholar
• Lovas K, Loge JH, Husebye ES. Subjective health status in Norwegian patients with Addison’s disease. Clin Endocrinol (Oxf) 2002;56(5):581-8
   PubMed Web of Science ®Google Scholar
• Scott RS, Donald RA, Espiner EA. Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy. Clin Endocrinol (Oxf) 1978;9(6):571-6
   PubMed Web of Science ®Google Scholar
• Groves RW, Toms GC, Houghton BJ, Monson JP. Corticosteroid replacement therapy: twice or thrice daily? J R Soc Med 1988;81(9):514-16
   PubMed Web of Science ®Google Scholar
• Dallman MF, Akana SF, Levin N, et al. Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis. Ann N Y Acad Sci 1994;746:22-31; discussion 31-2, 64-7
   PubMed Web of Science ®Google Scholar
• Walker JJ, Terry JR, Lightman SL. Origin of ultradian pulsatility in the hypothalamic-pituitary-adrenal axis. Proc Biol Sci 2010;277(1688):1627-33
   PubMed Web of Science ®Google Scholar
• Buijs RM, Wortel J, Van Heerikhuize JJ, et al. Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur J Neurosci 1999;11(5):1535-44
   PubMed Web of Science ®Google Scholar
• Jasper MS, Engeland WC. Splanchnic neural activity modulates ultradian and circadian rhythms in adrenocortical secretion in awake rats. Neuroendocrinology 1994;59(2):97-109
   PubMed Web of Science ®Google Scholar
• Oster H, Damerow S, Kiessling S, et al. The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock. Cell Metab 2006;4(2):163-73
   PubMed Web of Science ®Google Scholar
• Veldhuis JD, Iranmanesh A, Lizarralde G, Johnson ML. Amplitude modulation of a burstlike mode of cortisol secretion subserves the circadian glucocorticoid rhythm. Am J Physiol 1989;257(1 Pt 1):E6-14
   PubMedGoogle Scholar
• Son GH, Chung S, Choe HK, et al. Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production. Proc Natl Acad Sci USA 2008;105(52):20970-5
   PubMed Web of Science ®Google Scholar
• Follenius M, Simon C, Brandenberger G, Lenzi P. Ultradian plasma corticotropin and cortisol rhythms: time-series analyses. J Endocrinol Invest 1987;10(3):261-6
   PubMed Web of Science ®Google Scholar
• Windle RJ, Wood SA, Shanks N, et al. Ultradian rhythm of basal corticosterone release in the female rat: dynamic interaction with the response to acute stress. Endocrinology 1998;139(2):443-50
   PubMed Web of Science ®Google Scholar
• Walker JJ, Spiga F, Waite E, et al. The origin of glucocorticoid hormone oscillations. PLoS Biol 2012;10(6):e1001341
   PubMed Web of Science ®Google Scholar
• Henley DE, Leendertz JA, Russell GM, et al. Development of an automated blood sampling system for use in humans. J Med Eng Technol 2009;33(3):199-208
   PubMedGoogle Scholar
• Lightman SL, Wiles CC, Atkinson HC, et al. The significance of glucocorticoid pulsatility. Eur J Pharmacol 2008;583(2-3):255-62
   PubMed Web of Science ®Google Scholar
• Henley DE, Russell GM, Douthwaite JA, et al. Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy. J Clin Endocrinol Metab 2009;94(11):4234-42
   PubMed Web of Science ®Google Scholar
• Rivest RW, Schulz P, Lustenberger S, Sizonenko PC. Differences between circadian and ultradian organization of cortisol and melatonin rhythms during activity and rest. J Clin Endocrinol Metab 1989;68(4):721-9
   PubMed Web of Science ®Google Scholar
• Veldhuis JD, Roelfsema F, Iranmanesh A, et al. Basal, pulsatile, entropic (patterned), and spiky (staccato-like) properties of ACTH secretion: impact of age, gender, and body mass index. J Clin Endocrinol Metab 2009;94(10):4045-52
   PubMed Web of Science ®Google Scholar
• Hammond GL, Smith CL, Underhill DA. Molecular studies of corticosteroid binding globulin structure, biosynthesis and function. J Steroid Biochem Mol Biol 1991;40(4-6):755-62
   PubMed Web of Science ®Google Scholar
• Ballard PL. Delivery and transport of glucocorticoids to target cells. Monogr Endocrinol 1979;12:25-48
   PubMedGoogle Scholar
• Breuner CW, Orchinik M, Hahn TP, et al. Differential mechanisms for regulation of the stress response across latitudinal gradients. Am J Physiol Regul Integr Comp Physiol 2003;285(3):R594-600
   PubMed Web of Science ®Google Scholar
• Droste SK, de Groote L, Atkinson HC, et al. Corticosterone levels in the brain show a distinct ultradian rhythm but a delayed response to forced swim stress. Endocrinology 2008;149(7):3244-53
   PubMed Web of Science ®Google Scholar
• Qian X, Droste SK, Lightman SL, et al. Circadian and ultradian rhythms of free glucocorticoid hormone are highly synchronized between the blood, the subcutaneous tissue, and the brain. Endocrinology 2012;153(9):4346-53
   PubMed Web of Science ®Google Scholar
• Bhake RC, Leendertz JA, Linthorst AC, Lightman SL. Automated 24-hours sampling of subcutaneous tissue free cortisol in humans. J Med Eng Technol 2013;37(3):180-4
   PubMedGoogle Scholar
• De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998;19(3):269-301
   PubMed Web of Science ®Google Scholar
• Norman AW, Mizwicki MT, Norman DP. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 2004;3(1):27-41
   PubMed Web of Science ®Google Scholar
• Orchinik M, Murray TF, Moore FL. A corticosteroid receptor in neuronal membranes. Science 1991;252(5014):1848-51
   PubMed Web of Science ®Google Scholar
• Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 2003;23(12):4850-7
   PubMed Web of Science ®Google Scholar
• Orchinik M, Murray TF, Franklin PH, Moore FL. Guanyl nucleotides modulate binding to steroid receptors in neuronal membranes. Proc Natl Acad Sci USA 1992;89(9):3830-4
   PubMed Web of Science ®Google Scholar
• Lowenberg M, Verhaar AP, van den Brink GR, Hommes DW. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol Med 2007;13(4):158-63
   PubMed Web of Science ®Google Scholar
• Whiting KP, Restall CJ, Brain PF. Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms. Life Sci 2000;67(7):743-57
   PubMed Web of Science ®Google Scholar
• Buttgereit F, Scheffold A. Rapid glucocorticoid effects on immune cells. Steroids 2002;67(6):529-34
   PubMed Web of Science ®Google Scholar
• Urbach V, Walsh DE, Mainprice B, et al. Rapid non-genomic inhibition of ATP-induced Cl- secretion by dexamethasone in human bronchial epithelium. J Physiol 2002;545(Pt 3):869-78
   PubMed Web of Science ®Google Scholar
• Wang D, Zhang H, Lang F, Yun CC. Acute activation of NHE3 by dexamethasone correlates with activation of SGK1 and requires a functional glucocorticoid receptor. Am J Physiol Cell Physiol 2007;292(1):C396-404
   PubMed Web of Science ®Google Scholar
• Di S, Malcher-Lopes R, Marcheselli VL, et al. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology 2005;146(10):4292-301
   PubMed Web of Science ®Google Scholar
• Keller-Wood ME, Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocr Rev 1984;5(1):1-24
   PubMed Web of Science ®Google Scholar
• Russell GM, Henley DE, Leendertz J, et al. Rapid glucocorticoid receptor-mediated inhibition of hypothalamic-pituitary-adrenal ultradian activity in healthy males. J Neurosci 2010;30(17):6106-15
   PubMed Web of Science ®Google Scholar
• Dallman MF. Fast glucocorticoid actions on brain: back to the future. Front Neuroendocrinol 2005;26(3-4):103-8
   PubMed Web of Science ®Google Scholar
• Kaneko M, Hiroshige T. Fast, rate-sensitive corticosteroid negative feedback during stress. Am J Physiol 1978;234(1):R39-45
   PubMed Web of Science ®Google Scholar
• Roozendaal B, Quirarte GL, McGaugh JL. Glucocorticoids interact with the basolateral amygdala beta-adrenoceptor–cAMP/cAMP/PKA system in influencing memory consolidation. Eur J Neurosci 2002;15(3):553-60
   PubMed Web of Science ®Google Scholar
• Mikics E, Kruk MR, Haller J. Genomic and non-genomic effects of glucocorticoids on aggressive behavior in male rats. Psychoneuroendocrinology 2004;29(5):618-35
   PubMed Web of Science ®Google Scholar
• Sandi C, Venero C, Guaza C. Novelty-related rapid locomotor effects of corticosterone in rats. Eur J Neurosci 1996;8(4):794-800
   PubMed Web of Science ®Google Scholar
• Hastings MH, Maywood ES, Reddy AB. Two decades of circadian time. J Neuroendocrinol 2008;20(6):812-19
   PubMed Web of Science ®Google Scholar
• Reddy AB, Maywood ES, Karp NA, et al. Glucocorticoid signaling synchronizes the liver circadian transcriptome. Hepatology 2007;45(6):1478-88
   PubMed Web of Science ®Google Scholar
• Kornmann B, Schaad O, Bujard H, et al. System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock. PLoS Biol 2007;5(2):e34
   PubMed Web of Science ®Google Scholar
• Charmandari E, Chrousos GP, Lambrou GI, et al. Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. PLoS One 2011;6(9):e25612
   PubMed Web of Science ®Google Scholar
• Durrington HJ, Farrow SN, Loudon AS, Ray DW. The circadian clock and asthma. Thorax 2014;69(1):90-2
   PubMed Web of Science ®Google Scholar
• Lightman SL, Conway-Campbell BL. The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nat Rev Neurosci 2010;11(10):710-18
   PubMed Web of Science ®Google Scholar
• Martin K, Santoro N, Hall J, et al. Clinical review 15: management of ovulatory disorders with pulsatile gonadotropin-releasing hormone. J Clin Endocrinol Metab 1990;71(5):1081A-G
   PubMed Web of Science ®Google Scholar
• Engel JB, Schally AV. Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Pract Endocrinol Metab 2007;3(2):157-67
   PubMedGoogle Scholar
• Spiga F, Waite EJ, Liu Y, et al. ACTH-dependent ultradian rhythm of corticosterone secretion. Endocrinology 2011;152(4):1448-57
   PubMed Web of Science ®Google Scholar
• Stavreva DA, Wiench M, John S, et al. Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat Cell Biol 2009;11(9):1093-102
   PubMed Web of Science ®Google Scholar
• Matthews L, Johnson J, Berry A, et al. Cell cycle phase regulates glucocorticoid receptor function. PLoS One 2011;6(7):e22289
   PubMedGoogle Scholar
• Sarabdjitsingh RA, Conway-Campbell BL, Leggett JD, et al. Stress responsiveness varies over the ultradian glucocorticoid cycle in a brain-region-specific manner. Endocrinology 2010;151(11):5369-79
   PubMed Web of Science ®Google Scholar
• Haller J, Halasz J, Mikics E, et al. Ultradian corticosterone rhythm and the propensity to behave aggressively in male rats. J Neuroendocrinol 2000;12(10):937-40
   PubMed Web of Science ®Google Scholar
• Rankin J, Walker JJ, Windle R, et al. Characterizing dynamic interactions between ultradian glucocorticoid rhythmicity and acute stress using the phase response curve. PLoS One 2012;7(2):e30978
   PubMedGoogle Scholar
• Lightman S, Terry JR. The importance of dynamic signalling for endocrine regulation and drug development: relevance for glucocorticoid hormones. Lancet Diabetes Endocrinol 2014;2(7):593-9
   Google Scholar
• Groeneweg FL, Karst H, de Kloet ER, Joels M. Rapid non-genomic effects of corticosteroids and their role in the central stress response. J Endocrinol 2011;209(2):153-67
   PubMed Web of Science ®Google Scholar
• Windle RJ, Wood SA, Kershaw YM, et al. Increased corticosterone pulse frequency during adjuvant-induced arthritis and its relationship to alterations in stress responsiveness. J Neuroendocrinol 2001;13(10):905-11
   PubMed Web of Science ®Google Scholar
• Aksentijevich S, Whitfield HJ Jr, Young WS III, et al. Arthritis-susceptible Lewis rats fail to emerge from the stress hyporesponsive period. Brain Res Dev Brain Res 1992;65(1):115-18
   PubMedGoogle Scholar
• Sternberg EM, Hill JM, Chrousos GP, et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 1989;86(7):2374-8
   PubMed Web of Science ®Google Scholar
• Hartmann A, Veldhuis JD, Deuschle M, et al. Twenty-four hour cortisol release profiles in patients with Alzheimer’s and Parkinson’s disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol Aging 1997;18(3):285-9
   PubMed Web of Science ®Google Scholar
• Young EA, Carlson NE, Brown MB. Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology 2001;25(2):267-76
   PubMed Web of Science ®Google Scholar
• Deuschle M, Schweiger U, Weber B, et al. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 1997;82(1):234-8
   PubMed Web of Science ®Google Scholar
• Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004;25(9):735-41
   PubMed Web of Science ®Google Scholar
• Ahmed QA. Metabolic complications of obstructive sleep apnea syndrome. Am J Med Sci 2008;335(1):60-4
   PubMed Web of Science ®Google Scholar
• van den Berg G, Frolich M, Veldhuis JD, Roelfsema F. Combined amplification of the pulsatile and basal modes of adrenocorticotropin and cortisol secretion in patients with Cushing’s disease: evidence for decreased responsiveness of the adrenal glands. J Clin Endocrinol Metab 1995;80(12):3750-7
   PubMed Web of Science ®Google Scholar
• van den Berg G, Pincus SM, Veldhuis JD, et al. Greater disorderliness of ACTH and cortisol release accompanies pituitary-dependent Cushing’s disease. Eur J Endocrinol 1997;136(4):394-400
   PubMed Web of Science ®Google Scholar
• Raff H, Findling JW. A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 2003;138(12):980-91
   PubMed Web of Science ®Google Scholar
• van Staa TP, Leufkens HG, Abenhaim L, et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology 2000;39(12):1383-9
   PubMed Web of Science ®Google Scholar
• Van Staa TP, Abenhaim L, Cooper C, et al. The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf 2000;9(5):359-66
   PubMed Web of Science ®Google Scholar
• Fardet L, Petersen I, Nazareth I. Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing’s syndrome: cohort study. Bmj 2012;345:e4928
   PubMed Web of Science ®Google Scholar
• Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 2004;141(10):764-70
   PubMed Web of Science ®Google Scholar
• Blackburn D, Hux J, Mamdani M. Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly. J Gen Intern Med 2002;17(9):717-20
   PubMed Web of Science ®Google Scholar
• Mazziotti G, Angeli A, Bilezikian JP, et al. Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 2006;17(4):144-9
   PubMed Web of Science ®Google Scholar
• Franklin J, Lunt M, Bunn D, et al. Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis 2007;66(3):308-12
   PubMed Web of Science ®Google Scholar
• Mills JL, Schonberger LB, Wysowski DK, et al. Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr 2004;144(4):430-6
   PubMed Web of Science ®Google Scholar
• Lovas K, Gebre-Medhin G, Trovik TS, et al. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 2003;88(3):1112-18
   PubMed Web of Science ®Google Scholar
• Knapen MHJM, Puts P, van Schaik-Goodfellow MA. Addison patients in the Netherlands. Social report of the survey. Dutch Addison Society; The Hague, NL: 1993
   Google Scholar
• Ekman B, Bachrach-Lindstrom M, Lindstrom T, et al. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency. Clin Endocrinol (Oxf) 2012;77(1):18-25
   PubMed Web of Science ®Google Scholar
• Debono M, Ghobadi C, Rostami-Hodjegan A, et al. Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab 2009;94(5):1548-54
   PubMed Web of Science ®Google Scholar
• Johannsson G, Nilsson AG, Bergthorsdottir R, et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab 2012;97(2):473-81
   PubMed Web of Science ®Google Scholar
• Oksnes M, Bjornsdottir S, Isaksson M, et al. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison’s disease: a randomized clinical trial. J Clin Endocrinol Metab 2014;99(5):1665-74
   PubMed Web of Science ®Google Scholar
• Lovas K, Husebye ES. Continuous subcutaneous hydrocortisone infusion in Addison’s disease. Eur J Endocrinol 2007;157(1):109-12
   PubMed Web of Science ®Google Scholar
• Nilsson AG, Marelli C, Fitts D, et al. Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency. Eur J Endocrinol 2014;171(3):369-77
   PubMed Web of Science ®Google Scholar
• Verma S, Vanryzin C, Sinaii N, et al. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2010;72(4):441-7
   PubMed Web of Science ®Google Scholar
• Esteban NV, Loughlin T, Yergey AL, et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 1991;72(1):39-45
   PubMed Web of Science ®Google Scholar
• Kerrigan JR, Veldhuis JD, Leyo SA, et al. Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 1993;76(6):1505-10
   PubMed Web of Science ®Google Scholar
• Mah PM, Jenkins RC, Rostami-Hodjegan A, et al. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 2004;61(3):367-75
   PubMed Web of Science ®Google Scholar
• Gagliardi L, Nenke MA, Thynne TR, et al. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomised, placebo-controlled clinical trial. J Clin Endocrinol Metab 2014. jc20142433
   Google Scholar
• Russell GM, Durant C, Ataya A, et al. Subcutaneous pulsatile glucocorticoid replacement therapy. Clin Endocrinol (Oxf) 2014;81(2):289-93
   PubMed Web of Science ®Google Scholar
• Quan L, Zhang Y, Crielaard BJ, et al. Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. ACS Nano 2014;8(1):458-66
   PubMed Web of Science ®Google Scholar
• Elbialy NS, Abdol-Azim BM, Shafaa MW, et al. Enhancement of the ocular therapeutic effect of prednisolone acetate by liposomal entrapment. J Biomed Nanotechnol 2013;9(12):2105-16
   PubMed Web of Science ®Google Scholar
• Decani S, Federighi V, Baruzzi E, et al. Iatrogenic Cushing’s syndrome and topical steroid therapy: case series and review of the literature. J Dermatolog Treat 2014;25(6):495-500
   PubMed Web of Science ®Google Scholar
• Wolkowitz OM, Reus VI, Weingartner H, et al. Cognitive effects of corticosteroids. Am J Psychiatry 1990;147(10):1297-303
   PubMed Web of Science ®Google Scholar
• Newcomer JW, Selke G, Melson AK, et al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 1999;56(6):527-33
   PubMed Web of Science ®Google Scholar
• Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 1983;5(4):319-32
   PubMed Web of Science ®Google Scholar
• Henckens MJ, van Wingen GA, Joels M, Fernandez G. Time-dependent effects of cortisol on selective attention and emotional interference: a functional MRI study. Front Integr Neurosci 2012;6:66
   PubMedGoogle Scholar
• Henckens MJ, Pu Z, Hermans EJ, et al. Dynamically changing effects of corticosteroids on human hippocampal and prefrontal processing. Hum Brain Mapp 2012;33(12):2885-97
   PubMed Web of Science ®Google Scholar
• Whitehead G, Jo J, Hogg EL, et al. Acute stress causes rapid synaptic insertion of Ca2+ -permeable AMPA receptors to facilitate long-term potentiation in the hippocampus. Brain 2013;136(Pt 12):3753-65
   PubMedGoogle Scholar
• Joels M, Karst H, Alfarez D, et al. Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress 2004;7(4):221-31
   PubMed Web of Science ®Google Scholar
• Darwin C. The origin of the species by means of natural selection, or the preservation of favoured races in the struggle for life. 6th edition. John Murray; London: 1872
   Google Scholar
• Oksnes M, Bensing S, Hulting AL, et al. Quality of life in European patients with Addison’s disease: validity of the disease-specific questionnaire AddiQoL. J Clin Endocrinol Metab 2012;97(2):568-76
   PubMed Web of Science ®Google Scholar